The most common translocations in childhood T cell acute lymphoblastic leukemias involve the LMO2 locus on chromosome 11p13 and cause ectopic expression of the LMO2 gene in thymocytes. Transgenic mice with enforced expression of LMO2 in their thymocytes develop T cell leukemias thus demonstrating the role of LMO2 in leukemogenesis. The physiologic and leukemogenic functions of LMO2 are mediated through its transcriptional regulatory activities, but the identity of the target genes is completely unknown. In this report, we have used cDNA representational difference analysis (cDNA-RDA) to identify genes that are over-expressed and are likely to play a role in the LMO2 induced leukemias. cDNA-RDA was performed using very small amounts of mRNA pool (from 1 g of total RNA) to reverse transcribe the cDNAs from leukemic cells or normal thymocytes. The cDNA-RDA led to the isolation of nine distinct clones that were specifically overexpressed in the leukemic cells. Sequence analysis revealed that five of the nine clones had identity or homology to known genes that are known to play a role in the pathogenesis of leukemias or other cancers. Three clones had no significant homology to any known genes and thus represent novel candidate genes. Our study demonstrates that cDNA-RDA using very small amounts of total RNA is a highly efficient method to identify novel genes that may play a role in leukemogenesis.
Introduction
Acute lymphocytic leukemias (ALL) are the most common form of cancer in children. 1 A characteristic feature of childhood ALL is the presence of chromosomal translocations, juxtaposing two different regions of the genome. 2 Molecular analysis of chromosomal translocations in ALL has been instrumental in the identification of novel human proto-oncogenes. These analyses have revealed that genes specifying transcription factors are the most frequent targets of the changes brought about by these translocations. 2 Translocations cause two types of change. In one type, a chimeric fusion transcription factor, with altered specificity, is generated when the breakpoint occurs in the coding regions of the affected genes. In the second type of change the translocation breakpoint resides in the regulatory regions of a proto-oncogene resulting in increased, and usually ectopic expression of a structurally intact transcription factor. Thus, altered or ectopic expression of proto-oncogenes is thought to contribute towards the pathogenesis of human leukemias.
Translocation to the LMO2 (RBTN-2/TTG-2) locus represents the second type of change to a proto-oncogene. The LMO2 locus at chromosome 11p13 is the most frequent site of chromosomal translocation in childhood T cell ALL. [3] [4] [5] Translocations to this locus invariably result in ectopic expression of normal LMO2. 6 While LMO2 is expressed in virtually every tissue in fetal and adult life, it is not expressed in thymocytes or mature T cells. 7 Transgenic mice with enforced expression of LMO2 in thymocytes develop T cell leukemias, thus demonstrating the role of aberrant/ectopic expression of LMO2 in the pathogenesis of T cell leukemias. [8] [9] [10] Oncogenic effects of LMO2 are lineage specific; generalized overexpression of LMO2 in transgenic mice resulted only in T cell leukemias. 10 One normal function of LMO2 is in erythropoiesis; homozygous null mice lacking LMO2 die in utero around day 11 due to lack of red blood cells in the embryonic yolk sac. 11 In both its normal and leukemogenic roles LMO2 protein is thought to act as a transcription regulator, both because it is located in the nucleus 7 and because it forms complexes with the transcription factors RBP-2, tal-1, GATA-1, and GATA-2. [12] [13] [14] We have also identified a novel transcription factor, ELF2, belonging to the ets family of transcription factors, that associates with LMO2 and may play a role in leukemogenesis. 15 Additionally, we have recently demonstrated that LMO2 is a complex transcription factor, possessing multiple transcription regulatory modules, including two activation domains and two repression domains. 16 Thus, the preponderance of evidence suggests that LMO2, in association with other transcription factors, executes its functions by altering the transcription of its target genes. However, the identity of genes that perform the effector functions is completely unknown.
In this paper, we have utilized cDNA representational difference analysis (RDA), to identify clones that are differentially expressed between LMO2-induced leukemic cells and the normal thymocytes. We have examined the expression of these clones in normal thymocytes, LMO2-induced leukemias, and cell lines derived from these tumors to identify genes whose expression is altered in the leukemias. We identified nine clones whose expression is upregulated in LMO2-induced primary tumors and in cell lines derived from these tumors. Six of the clones represent known genes whereas the remaining three clones have identity/homology to the ESTs in the database. The six known genes with the exception of ␦ chain of T cell receptor (TCR) are known to be involved in the pathogenesis of leukemias and other cancers. We, therefore, expect that the novel genes represented by the three clones will also be involved in the leukemogenesis.
Materials and methods

Amplicon synthesis
Double stranded cDNA was synthesized on beads from thymocyte mRNA using procedures based on those of Rosok et al, 17 Braun et al, 18 and Hubank and Schatz. 19 Samples containing 1 g of total thymocyte RNA 20 were suspended in 10 l of water and heated at 65°C for 5 min. Twenty-five picomoles of biotinylated oligo dT (Promega, Madison, WI, USA) were added to anneal to the messages while the mixture cooled slowly to room temperature. The hybridized message was captured by adding 200 g of streptavidin-coated magnetic beads (Dynabeads M-280 Streptavidin, Dynal, Oslo, Norway) in 0.1 ml of lysis buffer (100 mm Tris-Cl (8.3), 500 mm LiCl, 10 mm EDTA, 1% SDS and 5 mm dithiothreitol). After a 10-20 min incubation at room temperature the beads were washed twice with 0.5 ml aliquots of washing buffer (10 Tris-Cl (8.3), 2 m LiCl, 1 mm EDTA) followed by 0.5 ml of RT buffer (50 mm Tris-Cl (8.2), 75 mm KCl and 3 mm MgCl 2 ), transfer to a new tube and then washed one more time with 0.1 ml RT buffer. First strand cDNA was synthesized by suspending the beads in 20 l of first strand buffer (1× Superscript buffer (Life Technologies, Grand Island, NY, USA), 10 mm dithiothreitol, 100 g/ml BSA, 0.5 mm dNTP, 200 units/ml RNasin and 5 units/ml Superscript II). The biotinylated oligo dT which attaches the mRNA to the beads was used as primer. The reaction was allowed to proceed for 1 h at 37°C with gentle stirring every 5 min. Second strand synthesis was initiated by addition of 20 l of second strand buffer (50 mm Tris-Cl (7.5), 100 mm KCl, 10 mm (NH 4 ) 2 SO 4 , 5 mm MgCl 2 , 50 g/ml BSA, 10 mm dithiothreitol, 150 mol beta-NAD, 0.1 mm dNTP, 10 units/ml RNase H, 250 units/ml E. coli DNA polymerase I and 100 unit/ml E. coli DNA ligase). The beads were incubated in this mixture for 3 h at 16°C with gentle stirring every 30 min. Double stranded cDNA was released from the beads by overnight digestion at 37°C with 1 unit of DpnII in the buffer supplied by NEB (Beverly, MA, USA), supplemented with 0.02% Tween-20 and covered with 30 l of light mineral oil. Subsequent reactions were as described by Braun et al, 18 with the exception that after the first round of amplification the reaction mixture was diluted into fresh PCR buffer and subjected to an additional 10-14 cycles of amplification.
Subtractive hybridizations and clone characterization
The hybridizations were as described by Hubank and Schatz. 19 The ratio of tester to driver was kept at 1:100 and 1:800 for the first and second subtractions, but we were unable to amplify difference product after hybridization unless we altered the amplification schedule to include 15 instead of 10 cycles of PCR prior to mungbean nuclease digestion. We left the second stage with 18 cycles of PCR, although subsequent experiments show that this number may be reduced to keep the total number of PCR cycles constant. Use of difference product as a probe of a Southern blot of the initial amplicons indicated strong differential representation of the Leukemia second difference product, so subtraction was stopped at this stage.
DNA from each band in the second difference product (DP2) was purified by electroelution from gels and ligated into Bluescript II vector. After transformation of DH5 alpha cells with the plasmids, individual colonies were selected and used to prepare plasmids. Purified plasmid inserts were arrayed on a dot blot 21 and screened with individual insert probes. Unique inserts were sequenced and used to probe Northern blots. Double inserts were identified by their digest pattern and subjected to sequencing if dot blotting could not identify the component inserts.
Northern blots
Northern blots were prepared from 10 g samples of total RNA isolated from tissue or cell samples. 20 The RNA was electrophoresed through a 1% agarose gel containing formaldehyde and was transferred by capillary action on to Nytran Plus membranes (Schleicher and Schuell, Keene, NH, USA) as previously described. 22 Probes were prepared using an Ambion (Austin, TX, USA) DecaPrime II kit and 
Results
Representational difference analysis (RDA)
To identify genes and understand their mechanism of action in leukemogenesis, we performed cDNA RDA to identify the differences in gene expression between LMO2-induced leukemic cells and normal thymocytes. In RDA, RNA populations are converted into ds cDNA libraries using 2-5 g of mRNA (equivalent of 100-200 g of total RNA) as a starting material for cDNA synthesis. 19, 23 However, in some cases, only a limited amount of RNA is available because the population of cells is present in small numbers. For these reasons, we have used a solid phase cDNA synthesis method that uses magnetic beads for solid support. 17 Using this method, we are able to generate excellent cDNA libraries from only approximately 1% of the RNA normally required, ie 1 g of total RNA. These libraries contain cDNA molecules representing less abundant messages such as Rag2 gene transcripts in thymocytes (data not shown).
The subtraction was performed using the tester to driver amplicon ratio of 1:100, 1:800 in two successive rounds of hybridization. An agarose gel analysis of the PCR products revealed selective enrichments of a distinct set of fragments after two rounds of amplification ( Figure 1a ). There was no significant difference in the overall pattern of PCR fragments between second and third rounds of subtraction (data not shown). We assessed the efficiency of the subtraction process by examining the difference products (DP) after each round of hybridization by Southern blot analysis. Clone a6, as . In contrast, the GAPDH probe hybridized equally well to driver and tester amplicons before subtraction suggesting that GAPDH is present in roughly equal amounts in both amplicon populations ( Figure 1c ). As expected, the GAPDH probe failed to hybridize to either first or second difference products ( Figure 1c ). These results show that cDNA from mRNAs common to both the tester and driver populations such as GAPDH are indeed diluted out during the subtractive hybridization, whereas cDNAs selectively present in tester such as clone a6 are highly enriched.
After two rounds of subtraction, the DP was analyzed on an agarose gel; each enriched fragment was purified and subcloned into the pBluescript KS. Thirty-one clones were isolated for characterization. Cross hybridization showed they represented 11 independent clones (data not shown). Since several independent clones were isolated only once, it is very likely that our RDA analysis does not represent saturation screening. To determine the differential expression, each independent clone was hybridized to the tester and driver amplicons. Nine clones showed differential expression, ie expression was much higher in tester than driver amplicons, whereas two false positive clones showed equal expression in both amplicons (data not shown). The differentially expressed clones were sequenced and a sequence homology search of the GenBank database conducted using FASTA program. As shown in Table 1 , four clones showed complete identity to the known cDNA (genes) and two clones were homologous, but not identical to known genes, indicating that they represent a novel member of the family. Two clones revealed no homology to known genes but showed complete identity to mouse sequence tags (EST), whereas one clone showed complete identity to a partially sequenced gene. These three clones presumably represent novel genes.
Northern blot analysis
Northern blot analysis was performed to determine the normal tissue expression pattern and to confirm the differential expression of the candidate genes. Total RNA was isolated either from adult normal mouse tissues, LMO2-induced tumors, or LMO2 tumor-derived cell lines, electrophoresed on an agarose gel, and hybridized to the cDNA clones. Clone a6 recognizes a 7.5 kb transcript which is expressed at low level in all adult tissues (Figure 2a) . Transcript represented by clone a6 is over-expressed (3-8-fold) in 50% of the LMO2-induced tumors (Figure 2b ). Its expression was also upregulated (fivefold) in an antigen-specific T cell clone (hen egg lysozyme peptide, aa 48-63) driven to proliferation in response to its cognate antigen (Figure 2c ). Data search revealed the existence of a partial cDNA clone (6.6 kb) that was sequenced as a part of large scale sequencing project. 24 The partial open reading frame (ORF) of this clone (2124 aa) reveals several intriguing features: it has a transmembrane region suggesting surface expression, a zinc finger, a sequence motif characteristic of topoisomerases, and a large stretch of CAG repeats (61 glutamine residues).
Receptor tyrosine phosphatase gene (clone a10) is normally expressed as a 3.8 kb transcript only in the brain and pancreas 25 ( Figure 3a) . However, it was ectopically expressed in 20% of the LMO2-induced tumors. Its expression was highly varied in the tumors but more surprising was the fact that in tumors only a truncated transcript of 2.6 kb was detectable (Figure 3b) . Hybridization of the tumor blot with a probe representing the 5Ј and 3Ј regions (see Materials and methods) indicated that the 2.6 kb transcript lacks 1.2 kb of the 5Ј end of the normal transcript. We have yet to determine whether expression of the truncated transcript represents receptor tyrosine phosphatase gene rearrangements or the use of a cryptic promoter. Cyclin D2 (clone a1) mRNA was detected as a 7 kb transcript in various normal adult mouse tissues (Figure 4a ). Cyclin D2 gene is overexpressed (3-5-fold), as compared to the normal thymocytes, in 40% of the LMO2-induced tumors (Figure 4b ). Clone b1 identifies two transcripts (4 and 9 kb) in Northern blot analysis whose expression is mostly restricted to brain and muscle in normal adult mouse (Figure 5a ). Proportionately higher amounts of shorter transcript are expressed in muscle, whereas it is present in much smaller amounts in brain. Clone b1 transcripts are not detectable in normal thymus (Figure 5a ) but it is ectopically expressed in two of the LMO2-induced tumors (Figure 5b ). About 80% of the LMO2-induced tumors form cell lines when grown under in vitro conditions. Panel c shows that cell lines derived from the same tumors also show 4 and 9 kb transcripts. Clone b1
Leukemia showed highest homology (53% nucleotide identity) to the neuropilin gene.
Clone a11 nucleotide sequence shows complete identity to the heat shock cognate 73 (hsc73) gene; it identifies a 2.3 kb transcript, which is expressed in all adult mouse tissues ( Figure  6a ). Hsc73 transcript is over-expressed (2-5-fold) in most of the LMO2-induced tumors. Clone b13 showed nucleotide and amino acid sequence homology, but not identity to mitotic checkpoint gene Bub1. We have recently sequenced a fulllength cDNA represented by the clone b13 and identified it as a new member of the Bub1 gene family, Bub1b. 26 Clone b13 identifies a 3.8-kb Bub1b transcript in high amounts in thymus and in barely detectable amounts in spleen of the adult mouse tissues (Figure 7a ). Bub1b transcript is overexpressed (2-4-fold) in 25% of the LMO2-induced tumors (Figure 7b) .
Clone a15 recognizes a 4 kb transcript which is expressed in all mouse adult tissues, but the highest levels are found in brain and kidney (Figure 8a ). Data search revealed no 
Figure 4
Overexpression of cyclin D2 gene in LMO2-induced tumors. The blots were hybridized to a probe representing the 5Ј untranslated region of the mRNA. Films were exposed for 3 days. Other details as in Figure 2 . homology or identity to any known gene, but clone a15 has complete nucleotide identity to a mouse EST (AA116241). Transcript identified by clone a15 is over-expressed in 30% of the LM02-induced tumors (Figure 8b) . Clone b5 recognizes a 3.5 kb transcript that is present in variable amounts in every adult mouse tissue (Figure 9a ). Sequence analysis showed no significant homology to any known gene but complete identity to a mouse EST (AA200749). Clone b5 is over-expressed in approximately 30% of the LMO2-induced tumors (Figure 9b ).
Discussion
Our objective is to identify the LMO2-induced genes that may play a role in leukemogenesis. Our experimental approach is to identify the genes that are differentially expressed between normal thymocytes and LMO2-induced leukemic cells. We hypothesize that differentially expressed genes are likely to play a role in conversion of normal thymocytes into leukemic cells. We have adapted a solid phase cDNA synthesis tech-
Figure 5
Clone b1 is ectopically expressed in some of the LMO2-induced tumors. Blots were hybridized with clone B1. Films were exposed for 3 days. Other details as in Figure 2 . (a) Transcripts recognized by clone b1 are normally expressed only in brain and muscle of the normal adult mice tissues. Note that larger transcript is more heavily expressed in brain whereas shorter transcript is in greater abundance in the muscle. nique 17 to prepare cDNA and amplicons from a small amount of total RNA. Using this approach, we are able to generate amplicons from 1 g of total RNA; a vast improvement over the normal requirements of approximately 100 g of total RNA or 2-5 g of polyadenylated RNA. 18, 19, 23 A major concern was that repeated amplification of a small amount of cDNAs may alter the complexity of cDNA (cellular mRNA) population, particularly that it may favor the isolation and identification of abundantly expressed genes. However, we are able to identify genes that are expressed at low level (eg clone b5) or whose expression differed only a few fold (eg cyclin D2 or the Bub1 homologue). Additionally, quantitative differences in the expression of the candidate clones (genes) in driver and tester amplicons closely paralleled those seen in Northern blot analysis (data not shown). Our results show that solid phase cDNA synthesis, using small amounts of RNA as Leukemia a template, allows proper representation of the total cellular mRNA population. Thus, our procedure will allow RDA of biological material that is available in very small amounts.
We found that RDA selectively enriches genes that are differentially expressed whereas genes that are expressed at similar levels in the tester and driver amplicons are eliminated through progressive rounds of subtractive hybridization (Figure 1 ). For RDA, the leukemic cells and normal thymocytes were matched for similar rate of proliferation (approximately 25% cells in S phase) and differentiation states (approximately 85% cells were CD4 + and CD8 + in both populations). Most probably for these reasons, genes like DNA polymerase that are normally upregulated in rapidly proliferating cells and genes related to differentiation state were not detected in our RDA screen. Since many of the independent clones were found only one time, it is likely that our RDA 
Figure 7
Mitotic check point gene Bub1b is overexpressed in some LMO2-induced tumors. The blots were hybridized to clone b13. Films were exposed for 3 days. Other details as in Figure 2 . screening does not represent saturation conditions. We identified 11 independent clones through our RDA screen. Hybridization of these clones to driver and tester amplicons (data not shown) and Northern blot analysis showed that nine clones were differentially expressed, whereas two clones were false positives since they had a similar level of expression in tester and driver cell populations. Thus, in our RDA screening, the rate of false positives is low and most of the clones represent genes that are differentially expressed.
Development of leukemia, similar to other cancers, requires multiple genetic changes caused by a diverse group of genes that inhibit apoptosis and/or provide growth advantage to the leukemic cells. We therefore expect that RDA will identify several oncogenes and expression of any one of these may occur only in a subset of LMO2-induced leukemias. It is difficult to argue that all the differentially expressed genes are causally related to the process of leukemogenesis. However, overexpression of a candidate gene in multiple tumors increases the probability that it is involved in leukemogenesis.
Of the nine differentially expressed clones, six represent known genes, whereas two are identical to mouse expressed sequenced tags (EST) and one clone represents a gene that has been partially sequenced. One of the differentially expressed clones identified through RDA was the ␦ chain of the T cell receptor gene. Its detection is not surprising since the tester, an LMO2-induced tumor, results from expansion of a single clone. 1 T cell receptor genes of each tumor are unique; isolation of the ␦ chain gene, in fact, provides strong evidence
Figure 8
Over-expression of gene represented by clone a15 in LMO2-induced tumors. The blots were hybridized to clone a15. Films were exposed for 3 days. Other details as in Figure 2 . (a) Normal expression of gene represented by clone a15 in adult mouse tissues. Transcript recognized by clone a15 is expressed in every tissue but the highest expression is in brain and kidney. (b) Transcript for clone a15 is overexpressed in tumors represented in lanes 1, 4, 7, 12, and 13.
Figure 9
Overexpression of gene represented by clone b5 in LMO2-induced tumors. The blots were hybridized with clone b5. Films were exposed for 3 days. Other details as in Figure 2 . (a) Clone b5 recognizes a 3.5 kb transcript in every adult tissue. (b) Transcripts recognized by clone b5 are overexpressed in tumors represented in lanes 2, 4, 7, 9, and 13. that our RDA indeed identifies differentially expressed genes. All the known genes, with the exception of the ␦ chain gene of the T cell receptor, have been reported to be involved in cancer pathogenesis. Receptor tyrosine phosphatase (RTP) IA2 gene is expressed only in brain and pancreas of normal adult mice or humans 25 ( Figure 3a) as a 3.8 kb transcript. However, it is ectopically expressed in approximately 20% of the LMO2-induced tumors. Its expression varied considerably among the tumors, but more surprising is the fact that in every tumor it is expressed in the form of a short, truncated transcript of 2.6 kb (Figure 3b ). RTP IA2 gene was originally isolated from a pheochromocytoma cell line. It is also overexpressed in other tumors of neuroendocrine origin including neuroblastomas (Xie et al 25 and our unpublished results). Receptor protein tyrosine phosphatases, because of their role in mitogenic signal transduction pathways, have been implicated in pathogenesis of various cancers. 27 In this context, it is noteworthy that RTP IA2 is expressed in barely detectable amounts Leukemia in quiescent cells but it is highly expressed in proliferating cells and its expression is induced by mitogenic stimulation of quiescent cells. 28 It is likely therefore that RTP IA2 may also play a role in LMO2-induced leukemias.
Cyclin D2 was overexpressed (3-5-fold) in approximately 40% of the LMO2-induced tumors (Figure 4b ). Cyclin D2 was detected as a 7.0-kb transcript in normal adult mouse tissues (Figure 4a ). Murine leukemia virus infection in mice results in the development of T cell leukemias. 29, 30 The infected mice show a common site of the proviral genome integration in the cyclin D2 gene locus which results in the overexpression of cyclin D2 protein. 30 These results strongly imply that overexpression of cyclin D2 is causally linked to the development of T cell leukemias. Similarly, overexpression of cyclin D1 in transgenic mice results in severe thymic hyperplasia and subsequent development of tumors. 31 It is likely, therefore, that cyclin D2 also plays a role in the pathogenesis of LMO2-induced T cell leukemias. Heat shock cognate 73 (hsc73) gene is a member of the hsp70 family. It is well expressed in every adult mice tissue ( Figure 6a) ; it is overexpressed in most of the LMO2-induced tumors (Figure 6b ). This gene is overexpressed in numerous tumors including breast carcinomas.
32
Hsc73 physically associates with retinoblastoma (Rb) and p53 proteins and presumably alters their function. 33, 34 Since Rb and p53 are involved in the pathogenesis of a wide variety of tumors, it is not unreasonable to suggest that hsc73 may also be involved in LMO2-induced leukemogenesis.
Clone b1 showed highest homology (53% identity) to the neuropilin 1 gene at the nucleotide level, similar to the homology between neuropilin 1 and 2 genes. These results imply that clone b1 represents a new neuropilin-related gene. Clone b1 recognizes two transcripts (4 and 9 kb) in muscle and brain of normal adult mouse. Clone b1 is ectopically expressed in two of the LMO2-induced tumors, though its expression showed considerable variation (Figure 6b ). About 80% of the LMO2-induced tumors form cell lines when grown under in vitro conditions (our unpublished results). The two cell lines derived from the positive tumors also showed expression of the two transcripts of the neuropilin-related gene (Figure 6c ). It has been recently reported that neuropilin-1 is an isoformspecific receptor for vascular endothelial growth factor (VEGF) in vascular endothelial cells. 35 VEGF is produced by the lymphocytes and it has a mitogenic effect on the endothelial cells. It may be that ectopic expression of a neuropilin-related gene, in the presence of endogenous VEGF produced by the leukemia cells, provides a growth advantage.
Clone b13 showed homology to mitotic checkpoint gene Bub1. We have recently cloned and sequenced the full length cDNA and found that clone b13 represents a second member of the Bub1 family. 26 Bub1 gene in yeast is required for proper chromosome segregation and its loss of function results in aneuploidy. 36, 37 Bub1 genes are mutated in approximately 20% of the colon carcinomas and loss of Bub1 function in colon carcinomas cell lines results in aneuploidy. 38 Aneuploidy is a prominent feature of acute lymphocytic leukemias in children 1 and LMO2-induced tumors in mice, 10 but it remains to be established whether or not Bub1 genes in LMO2-induced leukemias have mutations. Clone a6 recognizes a 7.5 kb transcript which is expressed at low level in all adult tissues (Figure 2a) . Data search revealed the existence of a partial cDNA clone (6.6 kb) that was sequenced as a part of a large scale sequencing project. 24 The partial open reading frame (ORF) of this clone (2124 aa) reveals several intriguing features: it has a transmembrane region suggesting surface expression, a zinc finger motif, a motif characteristic of topoisomerases, and a large stretch of CAG repeats (61 glutamine residues). Expansion of CAG/polyglutamine repeats in Huntington disease (HD) gene is sufficient to cause progressive neurological disorder in transgenic mice. 39 Clone a6 expression was also upregulated (approximately five-fold) in an antigen specific T cell clone (hen egg lysozyme peptide, aa 48-63) driven to proliferation in response to its cognate antigen (Figure 2c) . Transcript represented by clone a6 is overexpressed in approximately 50% of the LMO2-induced tumors (Figure 2b ). These results suggest that gene represented by clone a6 may play a role in LMO2-induced leukemogenesis.
Three clones (a6, a15, b2) represent novel genes. Their expression is upregulated in a subset of LMO2-induced tumors. The expression pattern of the three genes in normal tissues provides no clues to their function. Similarly, the functional significance of the three novel genes in LMO2-induced leukemias is yet to be determined. However, in view of the fact that clone a6 expression is upregulated in antigenically stimulated T cells and that the other known genes play a role in cancer pathogenesis, it is a reasonable expectation that the three novel genes identified through our RDA will also have a role in the pathogenesis of LMO2-induced leukemias.
Nine proto-oncogenes have been implicated in childhood T-ALL. 2 An intriguing aspect of T cell leukemias is that six of the nine proto-oncogenes involved in T cell leukemias, namely TAL-1, 40 45 are not expressed in normal thymocytes or mature T cells. The inappropriate or ectopic expression of these transcription factors, caused by translocation to the T cell receptor genes, is suspected to cause leukemia. Indeed, enforced expression of TAL-1, LMO1, LMO2, and Hox-11 7, 8, 40, 44, 45 in thymocytes of transgenic mice causes T cell leukemias. An important question then is: Does inappropriate expression of these transcription factors induce, at least in part, new pathway(s) of thymocyte proliferation or do these aberrantly expressed factors induce the normal proliferation pathway(s). Two of the LMO2 candidate target genes, namely RTP IA2 and the putative neuropilin related gene, were ectopically expressed, suggesting that leukemic cells in some of the LMO2-induced tumors recruit genes that presumably do not constitute the normal pathways of thymocyte proliferation.
Ectopically expressed genes such as RTP IA2 and putative neuropilin homologue are of considerable importance for prognosis and treatment of childhood T cell leukemias. After achieving remission, approximately 20% of the patients with T-ALL relapse due to resurgence of residual leukemic cells that cannot be detected during remission by morphological methods. 1 We 46,47 and others 48 have used a PCR based assay that detects clone-specific rearrangements of T cell receptor genes to measure residual leukemic cells during remission and to predict relapse. This assay is 100-1000 times more sensitive than morphological methods. But it is labor-intensive and time-consuming because clone-specific rearrangements have to be determined before the assay can be applied. No such requirement exists for the detection of ectopically expressed transcripts. We may find that one or more ectopically expressed candidate gene(s) in childhood T-ALL may provide a more rapid and simple assay. PCR-based detection of such transcript(s) will provide an equally sensitive but more direct and simple detection of residual leukemic cells and it can be used to predict impending relapse so that more intensive therapy could be administered when the tumor burden is low.
In summary, this study has shown the feasibility of cDNA-RDA using very small amounts of total RNA to isolate differentially expressed genes. All the known genes identified by us are known to play an important role in pathogenesis of leukemias and other cancers. It is therefore likely that the three novel genes identified in this study may also contribute towards the pathogenesis of LMO2-induced leukemias. Further studies on the differentially expressed genes identified here may provide better understanding of regulation of thymocyte proliferation and T cell leukemogenesis.
Note added in proof
The gene represented by the a6 clone (KIAA0192 or mopa protein) has recently been identified as TRAP 230, a component of a transcriptional activator complex described by Ito M, Yaun C-X, Malik S, Gu W, Fondell JD, Yamamura S, Fu Z-Y, Zhang X, Qin J, Roeder RG. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Molec Cell 1999; 3: 361-370.
